Arrhythmogenic right ventricular cardiomyopathy (ARVC), also referred to as Boxer Cardiomyopathy, is relatively common in Boxers and can lead to severe problems like malignant arrhythmias, heart failure, or sudden death. Notably, the Boxer breed is considered a natural model for the same disease in people. The primary goal in managing ARVC is to diagnose the disease before any symptoms arise. However, the challenge remains that there is no reliable diagnostic test available for early disease detection.
In a bid to reveal unique cardiac biomarkers among Boxers with ARVC, our pioneering research aims to provide essential insights into their cardiovascular health. As part of this effort, we're in the process of collecting blood samples from Boxers. Through our investigation, we will delve into potential circulating biomarkers, including microRNAs, antibodies, and genetic mutations.
Our team of dedicated veterinarians and scientists is ready to guide you through the study, ensuring your Boxer's comfort and safety at every step. Your participation will help us develop better diagnostic tools and treatment options, hopefully leading to longer, healthier lives for Boxer dogs.
Whether you have a young adult companion (2 years or older), or a wise senior, all ages and stages of Boxers are welcome to join this important research endeavor. Let's come together as a community of Boxer lovers to make a significant impact on their cardiac health!
To learn more about this groundbreaking study, please contact us at HeartBark@purdue.edu. Join us in unlocking the secrets of Boxer hearts!
